Overview

A Drug-Drug Interaction Study of Losartan and PA21

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine if Losartan potassium is affected by PA21.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Vifor Inc.
Vifor Pharma
Treatments:
Losartan
Criteria
Inclusion Criteria:

- Healthy volunteers

- Written informed consent

Exclusion Criteria:

- No significant medical conditions

- Pregnancy